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Capillary recruitmentThe cephalic phase of digestion (CPD) has been extensively investigated in terms of digestion and metabolism.
Nevertheless, microcirculatory changes required to prepare peripheral tissues in order to dispose nutrients
have never been assessed. In this study, microvascular function has been evaluated to determine its behavior
and potential association to hormonal secretions during CPD. Thirty-nine healthy male subjects, 23.4±
0.5 years (mean±SD) and BMI of 23.3±2.3 kg/m2, were randomized into receiving cognitive-sensorial stimuli
to elicit CPD (CPD group, n=20) or not (control group, n=19), after a 12-h overnight fast. Main outcomes were
differences in resting and peak functional capillary density (FCD, cap/mm2); resting red blood cell velocity
(RBCV), peak RBCV (RBCVmax) and time taken to reach it (TRBCVmax); peak ﬂow and vasomotion, before and
after CPD and their associations with insulin and/or pancreatic polypeptide (PP). In the CPD group, basal FCD
(24.9±7.6 to 28.3±8.1, p=0.005), peak FCD (27.8±6.3 to 32.6±7.1, p=0.002), RBCV (0.306±0.031 to
0.330±0.027 mm/s, p=0.005), RBCVmax (0.336±0.029 to 0.398±0.292 mm/s, p=0.005) and peak ﬂow
(23.5±14.3 to 26.9±15.8 PU, pb0.01) increased while TRBCVmax decreased (4.9±1.5 to 3.5±1.2 s, p=0.01).
No signiﬁcant changes could be detected in the control group. Groups have not presented differences for insulin,
but PP signiﬁcantly increased in the CPD group and was positively associated to basal FCD increase (rho=0.527,
p=0.03). In conclusion, neurally-mediated anticipatory responses of digestion elicited functional capillary re-
cruitment associated to PP in healthy men, suggesting a precocious role for microcirculation in the physiology
of digestion and nutrient homeostasis.
© 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
The cephalic phase of digestion (CPD) occurs before food consump-
tion and its effects can last from 10 to 60 min [1–5]. It results from sen-
sory and cognitive stimuli such as sight, smell, taste or thought of food
[2]. Cephalic-phase sensory stimuli reach the nucleus of the solitary
tract and dorsal motor nucleus of the vagus and they stimulate the re-
lease of hormones from the endocrine pancreas. This is consistent with
a neural-dependent stimulation rather than a nutrient-induced one
[5,6]. Insulin and pancreatic polypeptide (PP) secretions during CPD
have been extensively studied [1,2,7]. Their physiological signiﬁcance
remains to be elucidated, yet PP secretion during this phase accounts
for 16% of the total PP released during digestion [7].
Literature data about the effects of insulin secretion during the ce-
phalic phase point to its important role for the establishment of normal
glucose tolerance [3,8]: some authors have shown that it can determineltrials.gov.
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Aguiar).
evier OA license.an increment on insulin levels [9] while others have questioned this abil-
ity [10]. Nevertheless, neuralmediation of insulin during this periodmay
have multiple effects, ultimately facilitating metabolic homeostasis dur-
ing food ingestion [11]. Physiologically, this period is fundamental for
nutrient metabolism due to the early supply of insulin to tissues priming
its receptors and allowing further glucose metabolization [8,12].
Conceivably, regulation of glucose uptake in peripheral tissues in-
volves a vascular component. It implies an increase in nutritive perfu-
sion for its maximum delivery and storage in insulin-sensitive tissues,
which has been primarily shown in studies performed in skeletal
muscle [13]. However, bulk ﬂow does not necessarily reﬂect changes
in nutritive capillary perfusion achieved either by dilation or vasomo-
tion of terminal arterioles. Physiologically, insulin increases mainly in
response to blood glucose elevation. Investigations have not been
conducted on very low insulin increments and their consequent vaso-
active effects, which may occur in humans during CPD in the absence
of concomitant elevations in plasma glucose. Previous studies using
experimental animals have shown an increase in muscle capillary
perfusion long before the occurrence of any augmentation in bulk
blood ﬂow or glucose uptake [14]. In human subjects, physiological
insulin secretion and capillary recruitment have been investigated
only in relation to intestinal glucose absorption [15].
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role in glucose homeostasis [16] and impaired capillary recruitment
seems to be involved in insulin resistance due to decreased tissue per-
fusion [17,18]. Although hemodynamic effects of insulin have already
been demonstrated and well-tested [13,19,20], there are few studies
investigating alterations in microcirculation due to CPD — a period
in which endogenous pancreatic secretions should play an important
role. Taking into account that several nervous and hormonal signals
are activated during CPD [21,22], we have aimed to evaluate whether
microcirculatory changes might be related to them and discuss their
role in CPD in healthy subjects.2. Material and methods
2.1. Study design, subjects and setting
This was a randomized trial. Healthy subjects aged between 18 and
30 years were selected after clinical and laboratorial assessments. All
participants provided their written informed consent. The study was
approved by the institutional ethics committee (Pedro Ernesto Univer-
sity Hospital/Project 2145) and was carried out at the Clinical and Ex-
perimental Research Laboratory on Vascular Biology (BioVasc) of the
State University of Rio de Janeiro. GPower 3.1.10 software was used
for power analysis and sample size estimation. The statistical power
for comparisons between two dependent groups was above 0.8 with
an α-error probability of 0.05 for functional capillary density (Δ 3.64
cap/cm) [23], estimating a sample size of 14 subjects per group.
Subjects were submitted to a screening phase before being eligible
to participate in the study. This phase comprised measurements of
weight, height and percentage of body fat using a skin-fold thickness
protocol performed by a trained dietitian [24]. Subjects who were
smokers or presented high blood pressure (≥130×85 mm Hg) [25]
or any clinical condition were excluded. Subjects with body mass
index (BMI) lower or higher than 18.5–24.9 kg/m2 were also exclud-
ed. Those with BMI within the overweight range (25.0–29.9 kg/m2),
but showing a percentage of body fat below the average (b15%) for
male adults [24] were included in the study. Fasting glucose and insu-
lin, hemogram, total cholesterol, triglycerides, low and high density
lipoproteins, alanine (ALT) and aspartate (AST) transaminases and
creatinine were assessed after a 12-hour overnight fast. A 75-g oral
glucose tolerance test was also performed. Subjects presenting any
degree of glucose intolerance according to the American Diabetes As-
sociation criteria [26] or any other altered laboratorial results, were
excluded.
Forty-eight subjects were recruited. On the day of the trial, volun-
teers arrived at the laboratory after a 12-h overnight fast and were ac-
commodated in a temperature-controlled room (24±1 °C), on the
examination chair. Their blood pressure was checked using the stan-
dard auscultatory method. An intravenous catheter was inserted and
kept in place during the exam for blood samples withdrawal to assess
glucose, insulin and pancreatic polypeptide basal levels. After a 30-
min acclimatization period, the experiment was started. Subjects
were submitted to two microcirculatory evaluations, with a 10 min
interval between each other (Fig. 1). During the interval, according
to the randomization, volunteers were subjected to a sensorial stimu-
lation (CPD group, n=24) or nothing (control group, n=24).Fig. 1. Experimental design. BS: blood sample collection. SM: salivation measurement. V
presentation.2.2. Sensorial stimulation to trigger the cephalic phase of digestion
The aim of the stimulus was to trigger the cephalic phase of diges-
tion by placing in front of the volunteer a breakfast tray containing
their reported favorite food items. We have preferred to ask individ-
uals about their favorite choices of breakfast food items in order to
best elicit the sensorial stimulation. The tray was positioned where
the subject could see and smell it continuously but could not eat it be-
fore the end of the exam. Additionally, cognitive stimuli were
attempted by talking about the volunteer's food preferences.
Salivation was measured (Shirmer Test Stripes, Ophtalmos, São
Paulo, SP, Brazil) during 1 min at baseline and upon presentation of
the stimulus (or at time 0 for the control group). Afterwards, a
sugar-free chewing gum (to avoid any absorption bias) was given to
subjects that were presented to the sensorial stimulus, in order to
elicit oral stimulation. Blood samples were drawn at 3, 9 and 15 min
after the stimulus presentation (or after the end of the ﬁrst microcir-
culatory evaluation for the control group) to determine levels of insu-
lin and pancreatic polypeptide. This time frame was selected
according to literature evidence of insulin and pancreatic polypeptide
peaks during the cephalic phase [10,27]. Glucose levels were also
measured in both groups for glycemic control at minute 15.2.3. Microvascular function assessment
Skin microvascular assessment was used as a model of systemic
microcirculation [28]. For videocapillaroscopy, subjects were seated
comfortably in a ﬁxed, high-based chair with the left upper arm
raised at heart level. The forearm and hand (dorsal side up) were
rested upon a pedestal and the fourth ﬁnger supported by an acrylic
base. This base was mounted on the x–y stage of a three-eyepiece
Leica DM/LMmicroscope (Wetzlar, Germany) equipped with an epiil-
lumination system (100 W Xenon lamp). A CCD video camera (Sam-
sung, Seoul, South Korea) was coupled to the microscope and
connected to a DVD recorder (Samsung, Seoul, South Korea) and a
Kodo KBM1700E monitor (Seoul, South Korea). The ﬁngertip was
ﬁxed to the acrylic base by a metal ring to minimize the movements.
The skin temperature of the ﬁnger was monitored throughout the ex-
amination with an YSI Precision 4000A digital thermometer (Dayton,
Ohio, U.S.A.) with the thermistor probe taped within 1 cm proximal
to the nailfold. A drop of mineral oil was spread over the observation
site to improve image quality. A pressure cuff (1 cmwide) was placed
around the proximal phalanx and connected to a mercury manome-
ter. The exam was continuously recorded on DVDs for subsequent
measurements of microcirculatory parameters using the CapImage
software [29]. The analyses were performed by the same observer
blinded to the stimulus (data entry records were codiﬁed, thus, at
the time of the analysis the researcher did not know to which group
the volunteer belonged).
Two different approaches were applied when recording the nail-
fold area. This was a methodological strategy, in order to collect as
many microvascular variables as possible and to test whether or not
results pointed in the same direction. Subjects were randomized
according to one of the following methods. The dynamic nailfold
videocapillaroscopy [23,30] recorded data on red blood cell velocity
(RBCV) at rest, after 1 min arterial occlusion (RBCVmax) – whichideocap: videocapillaroscopy exam. The arrow indicates the time point of stimulus
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due to increased shear stress [31] – and the time taken to reach it
(TRBCVmax) with a ﬁnal magniﬁcation of ×680, before and during
the post-occlusive reactive hyperemia response (PORH). The dorsal
ﬁnger videocapillaroscopy validated and described elsewhere [32]
assessed only functional capillary density (FCD), i.e. the number of
capillaries/unit tissue area (mm2) with ﬂowing red blood cells. Brief-
ly, it estimates baseline capillary density by counting the number of
continuously red blood cell-perfused capillaries during a 15-second
period. Post-occlusive reactive hyperemia was also used to assess
capillary recruitment after 4-min ischemia, which is a methodologi-
cally appropriate time to assess such variable [32].2.4. Skin microvascular blood ﬂow and vasomotion
Measurements using laser Doppler ﬂowmetry (LDF) are based on
transmission of low-power laser light (780 nm) to the tissue via a
ﬁber-optic probe that penetrates the skin 0.4 to 1.0 mm. The extent
of light penetration enables the evaluation of net red blood cell ﬂux
[in arbitrary units (PU)] as the product of concentration of moving
blood cells and its velocity, in an area of approximately 1 mm2, in
capillaries, arterioles and venules, as well as in anastomosis of deeper
blood vessels in dermal layers [33]. Blood ﬂow and vasomotion were
recorded (Perimed AB, Stockholm, Sweden) throughout the experi-
ment (approximately 30 min) with the probe positioned at the dorsal
side of the left wrist.
Fast Fourier transform analysis was performed using Perisoft soft-
ware (PSWversion 2.50, Perimed AB, Stockholm, Sweden) to determine
the contribution of different vasomotion frequency components to the
variability of the signal. We have assumed ﬁve frequency intervals pre-
viously deﬁned [34] in the spectrumbetween 0.01 and 1.6 Hz: (1) endo-
thelial (0.01–0.02 Hz); (2) neurogenic (0.02–0.06 Hz); (3) myogenic
(0.06–0.15 Hz); (4) respiratory (0.15–0.4 Hz) and (5) heart beat
(0.4–1.6 Hz) activities. Absolute amplitude variations within each fre-
quency band were analyzed, as well as their normalized values, which
are the interval of the mean amplitude divided by the total spectrum
mean amplitude [34].Table 1
Anthropometrical and clinical characteristics between control and experimental (CPD)
groups at baseline.2.5. Insulin iontophoresis
All of the participants were subjected to transdermal iontophore-
sis of insulin [1.8 μl of solution: Humulin-R, Lilly, diluted (1/10) in
deionized water] at the end of the study protocol. This was also a
methodological strategy to assure their microvascular reactivity to
the hormone exogenously administered, as previously described in
healthy subjects [35]. Insulin was delivered with a cathodal current
during 12 doses (0.2 mA for 20 s) with 40-s interval between each
dose [35]. Baseline skin blood ﬂow was recorded for 2 min before
the protocol started. The ﬂow increment was calculated as the per-
cent increase of the area under the curve (AUC) subtracting baseline
AUC from plateau AUC which was reached in the last two doses.Control group (n=19) CPD group (n=20)
Age (y) 23.2±2.7 23.7±3.4
BMI (kg/m2) 23.3±2.1 23.3±2.5
Body fat (%) 14.3±5.1 12.9±5.3
Waist circumference (cm) 83±5.3 82.5±6.6
SBP (mm Hg) 117±4.2 110±11
DBP (mm Hg) 72±5.6 70±7.7
Fasting glucose (mg/dl) 84±5.3 84±5.8
Glucose post-OGTT (mg/dl) 81±18.6 74±18.8
Insulin (μU/dl) 6.9±2.3 5.8±1.9
Total cholesterol (mg/dl) 152±29.0 141±26.4
HDL-c (mg/dl) 49±7.3 48±7.1
LDL-c (mg/dl) 87±24.6 80±25.2
TG (mg/dl) 74±29.0 61±17.4
Values are mean±SD. BMI: Body mass index; SBP: systolic blood pressure; DBP:
diastolic blood pressure; OGTT: oral glucose tolerance test; TG: triglycerides2.6. Laboratory analyses
All laboratory measurements were performed in duplicate by an
automated method (Modular Analytics E 170 and P, Roche, Basel,
Switzerland) except for pancreatic polypeptide (PP), for which was
used the human enzyme-linked immunosorbent assay Kit (Millipore,
Massachusetts, USA). More speciﬁcally, serum insulin levels were an-
alyzed by electrochemiluminescence, plasma glucose levels by GOD-
PAP (enzymatic-colorimetric oxidase–peroxidase method) and
serum PP by ELISA and inter-assay coefﬁcients of variation were
10.6%, 1.1% and 8.5%, respectively. Analyses were performed by a
technician blinded to randomization.2.7. Outcomes and statistical analyses
The main outcomes of the trial were differences and correlations
between microvascular parameters assessed pre- and post-stimulus
and endocrine pancreatic hormonal changes during CPD. Parameters
of microvascular function were: basal functional capillary density
(FCD) and peak FCD during PORH measured by dorsal ﬁnger videoca-
pillaroscopy; afferent, efferent and apical diameters of capillary loops,
resting red blood cell velocity (RBCV), peak RBCV during PORH
(RBCVmax) and time taken to reach it (TRBCVmax) measured by dy-
namic nailfold videocapillaroscopy; changes in microﬂow and vaso-
motion frequencies assessed by LDF [36]. Data entry was performed
by a researcher blinded to the stimulus and randomization codes
were only opened after the completion of the study.
All of the variables were checked for normality. Clinical baseline
variables normally distributed were compared using Student's t-
test. Most microvascular and biochemical outcomes presented non-
parametrical distribution and intra-group differences pre- and post-
stimulus were analyzed using Wilcoxon matched-pairs test while
repeated measures used Friedman test followed by post-hoc Dunn's
test. Comparisons between groupswere assessed usingMann–Whitney
U test. Correlations between variables were tested through Spearman
rho test. Results are presented as mean±SD, unless otherwise noted,
as median (1st; 3rd quartiles). The level of signiﬁcance adopted was
0.05.
3. Results
Thirty-nine subjects aged 23.4±0.5 years with BMI 23.3±2.3 kg/
m2 and body fat 13.6±5.2% were included in the analysis. At base-
line, no signiﬁcant differences could be detected between control
and experimental (CPD) groups (Table 1). Blood samples of 9
(18.7%) subjects [5 in the control group and 4 in the CPD group]
were not evaluated due to poor sample quality, but no signiﬁcant dif-
ferences between excluded and included subjects were noticed (data
not shown — Supplementary Table 1).
3.1. Microvascular outcomes
Basal FCD signiﬁcantly increased in volunteers of the CPD group
while it did not change in controls, respectively: 24.9±7.6 to 28.3±
8.1 cap/mm2 or 13.7% increment, p=0.005 and 21.2±10.5 to 22.7±
9.2 cap/mm2 or 7.1% increment, p=0.2 (Table 2). Peak FCD during
PORH increased in the CPD (17.3% increment, p=0.002) but not in
the control group (1.7% decrement, p=0.38). Additionally, in the CPD
group we were also able to demonstrate increments in RBCV and in
Table 2
Microcirculatory parameters (mean±SD) measured by videocapillaroscopy in the
control and experimental (CPD) groups, pre- and post-stimulus presentation.
Control group CPD group
Videocapillaroscopy
method
Pre Post Pre Post
Dorsal ﬁnger (n=10) (n=10)
Resting FCD
(cap/mm2)
21.2±10.5 22.7±9.2 24.9±7.6 28.3±8.1⁎
FCD during PORH
(cap/mm2)
23.2±8.4 22.8±9.4 27.8±6.3 32.6±7.1†
Dynamic nailfold (n=9) (n=10)
RBCV (mm/s) 0.329
±0.018
0.328
±0.019
0.306
±0.031
0.330
±0.027⁎
RBCVmax (mm/s) 0.362
±0.021
0.360
±0.023
0.336
±0.029
0.398
±0.030⁎
TRBCVmax (s) 3.7±0.6 3.8±0.8 4.9±1.5 3.5±1.2‡
Values are mean±SD. FCD: functional capillary density; PORH: post-occlusive reactive
hyperemia; RBCV: red blood cell velocity; RBCVmax: peak red blood cell velocity;
TRBCVmax: time taken to reach RBCVmax.
Wilcoxon matched-pairs test difference pre- and post-stimulus.
⁎ p=0.005.
† p=0.009.
‡ p=0.01.
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the controls. No signiﬁcantmorphological differences were detected for
either group on studied diameters of capillary loops. Skin temperature
did not change signiﬁcantly throughout the protocol (CPD group,
p=0.6; control group, p=0.5).
Assessment of blood ﬂow by LDF showed a signiﬁcant increase in
peak ﬂow (perfusion units) in the CPD group (23.5±14.3 to 26.9±
15.8, p=0.01), but not in controls (19.5±9.0 to 20.5±11.0,
p=0.8) (Table 3). Baseline peak ﬂow was not different between
groups (p=0.65). CPD and control groups did not show any differ-
ences for frequency intervals and total spectrum of spontaneous
arteriolar vasomotion (Table 3). These comparisons remained non-
signiﬁcant even after values were normalized. Comparisons of pre-
and post-stimulus frequencies within groups were only possible in
the sub-sample (n=10 in each group) subjected to dorsal ﬁnger
videocapillaroscopy, due to the minimum time required to analyze
vasomotion (15 min). Microvascular responses to transdermal exoge-
nous insulin iontophoresis were not different between the CPD and
control groups, with both showing increments on microﬂow respec-
tively of 126.5 (38.6; 354.4) % and 90.2 (34.3; 395.5) %, p=0.65.
3.2. Cephalic phase markers
Baseline insulin [6 (5; 9) and 6 (4; 8) μU/ml, p=0.7] and PP [162.4
(72.3; 283.3) and 439.6 (111.3; 1149.6) pg/ml, p=0.08] levels wereTable 3
Microcirculatory parameters (mean±SD) measured by laser-Doppler ﬂowmetry in the
control and experimental (CPD) groups, pre- and post-stimulus presentation.
Control group (n=19) CPD group (n=20)
Pre Post Pre Post
Peak ﬂow (PU) 19.5±9.0 20.5±11.0 23.5±14.3 26.9±15.8a
Vasomotion (PU/Hz)b (n=10) (n=19) (n=10) (n=20)
Endothelial 0.70±0.32 0.85±0.35 0.66±0.33 0.97±0.79
Neurogenic 0.53±0.23 0.66±0.28 0.56±0.27 0.78±0.53
Myogenic 0.43±0.35 0.57±0.45 0.62±0.66 0.83±0.60
Respiratory 0.18±0.23 0.27±0.29 0.38±0.46 0.39±0.37
Cardiac 0.10±0.08 0.13±0.10 0.15±0.14 0.20±0.15
Values are mean±SD. PU: perfusion units.
a Wilcoxon matched-pairs test difference pre- and post-stimulus: p=0.01.
b Pre-stimulus intervals could not be analyzed in 9 subjects due to lack of minimum
measurement time.not signiﬁcantly different between control and CPD groups. Insulin
did not change from minutes 3 to 15 (Table 4) while PP levels signif-
icantly increased in the CPD group and remained unaltered in the
control group (median percentages: 2.4% and 0%, respectively;
p=0.02). After cephalic phase stimulation, absolute insulin levels [6
(3.5; 8) and 5 (4.5; 6) μU/ml, p=0.4] were not signiﬁcantly different
between control and CPD groups, respectively, while PP levels were
[150.3 (77.8; 345) and 480.6 (119.4; 1198.5) pg/ml, p=0.03]. In ad-
dition, salivation, a clinical marker of CPD, similar in both groups at
baseline (p=0.73), signiﬁcantly increased in the CPD but not in the
control group (median: 100% and 0%, respectively; pb0.001). No dif-
ferences could be detected in glucose levels at 15 min (p=0.07) for
none of the groups.
3.3. Correlations between endocrine outcomes and microcirculation dur-
ing CPD
Unaltered insulin levels limited our correlation analyses to PP
changes from minutes 3 to 15 and their associations to microvascular
reactivity during CPD. PP was positively associated with changes in
basal FCD in the CPD group (rho=0.527, p=0.03), but not in the
control group (Fig. 2). PP results of four patients in the CPD group
and ﬁve in the control group did not reach assay sensitivity
(12.3 pg/ml) and therefore were excluded from these analyses with-
out compromising the balance between the two groups (data not
shown — Supplementary Table 2). The variations in basal FCD post-
stimulus in these excluded subjects ranged from −10.0 to 10.5% in
the control group and from 4.0 to 18.2% in the CPD group.
4. Discussion
To the best of our knowledge, this is the ﬁrst study that demon-
strated an association between a hormonal secretion and functional
changes in both non-nutritive and nutritive microcirculatory param-
eters during CPD in healthy men. Our ﬁndings support that at pre-
ingestive stages of digestion there is not only an activation of
gastro-intestinal endo- and exocrine secretions but also, and concom-
itantly, capillary recruitment and an increase on microﬂow, the for-
mer being associated with PP increments. Despite the need for
augmented tissue perfusion in humans to allow nutrient exchange,
until now there were no data demonstrating the role of microcircula-
tion on such precocious stage of digestion and nutrient metabolism.
Rather than insulin, our data suggest that pancreatic polypeptide
(PP) may have a role during this phase. In fact, one recent study in
rats has shown that human PP evoked concentration-dependent re-
laxation of mesenteric small arteries by activation of pre-junctional
neuropeptide Y1-like receptors followed by the release of calcitonin
gene-related peptide and of endothelium-derived nitric oxide (NO)
[37]. Another experimental study also provided evidence for a direct
vascular action of acetylcholine secondary to parasympathetic stimu-
lation, as well as an indirect vasodilator effect of vasoreactive intesti-
nal peptide via NO formation [38]. The hypothesis of the observed
functional microcirculatory changes being due to both effects, as
well as to some insulin action (although its rise was not detectableTable 4
Changes in markers of cephalic phase of digestion [median (p25;p75)], from minutes 3
to 15.
Control group (n=19) CPD group (n=20)
Delta % Delta %
Insulin
(μU/ml)
0 (−1; 1) 0 (−17; 20) − 1 (−2; 1) −9 (−33; 20)
PP (pg/ml) 0.12 (−41; 15.3) 0 (−9.6; 4.5) 3.2 (−29; 32.3) 2.4 (−3.4; 6.3)a
Values are median (p25;p75). PP: Pancreatic Polypeptide.
a Mann–Whitney U test difference between groups: p=0.02.
Fig. 2. Spearman's rank correlation between changes in pancreatic polypeptide (PP) during cephalic phase stimulation (minutes 3–15) and basal functional capillary density (FCD)
in the CPD (n=16) and control (n=14) groups.
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it is possible that not only insulin [14] but other gastro-intestinal
peptides like PP, could play a role on vascular tissue during CPD.
The lack of increased insulin levels on the experimental group
cannot be deﬁned as unexpected in light of previous studies of CPD,
which have shown high-, low-, and negative responses of insulin se-
cretion to food sensorial stimulation in healthy subjects [2,39]. Low
increments of insulin could have occurred under the assay sensibility
and simultaneous sympathetic nervous system activation might have
also hindered the detection of insulin release [11]. Additionally, due
to low insulin increments previously observed in the absence of glu-
cose stimulation [2] we could also hypothetically suggest that the ab-
sence of detectable insulin increments on CPD group may also
represent its transendothelial passage to interstitial space and bind-
ing to cellular receptors as a consequence of enhanced microﬂow
[18]. The signiﬁcant rise in PP in this group gives us evidence of suc-
cessful stimulation of the cephalic phase of digestion [40]. In accor-
dance with our ﬁndings, it was shown that PP could increase even if
insulin is not incremented during CPD [5]. Its secretion is almost ex-
clusively dependent of vagal stimulus, which releases acetylcholine
in the pancreatic islet cells, also promoting secretion of insulin and
glucagon. Of note, we should emphasize that the observed signiﬁcant
rise of exocrine secretions by salivary glands was the main clinical
ﬁnding demonstrating an effective activation of the parasympathetic
system by thought, sense and/or anticipation of food intake [9] in
the experimental group.
Cutaneous blood ﬂow is a biological variable that ﬂuctuates dy-
namically and has substantial spatial heterogeneity. Nonetheless,
our results have pointed in the same direction, demonstrating the ex-
istence of functional changes in the microcirculation in healthy men
in different sites assessed by distinct techniques, thus suggesting an
involvement of the microcirculation in the CPD. Despite the fact that
microcirculatory assessment techniques in skin do not clearly express
physiological and pathophysiological alterations displayed in skeletal
muscle, the inference of ﬁndings in cutaneous tissue might bring new
concepts on glucose homeostasis and its relation to microcirculation.
As wisely pointed out by Holowatz and colleagues [28], cutaneous mi-
crovascular responses integrate neural, endothelial and vascular
smooth muscle contributions, and these complex interactions in vas-
cular signaling are the nature of human integrative physiology in vivo,
regardless of the microvascular bed being studied. In addition, our
ﬁnding of increased resting functional capillary density following
meal-mediated cognitive–sensorial stimulus is worth noting as a con-
sequence of the cephalic phase per se, since it is separated from the
compound stimuli involved in the reactive hyperemia. Further studies
are needed to clarify PP involvement in this situation.
Nutritive skin microcirculation was assessed by two distinct
methods, dynamic nailfold and dorsal ﬁnger videocapillaroscopies,
in order to supply as many parameters as possible for analyses.These two methods are well-validated and used by research groups
worldwide [17,32]. Laser-Doppler ﬂowmetry (LDF) measurements
were applied for analyses of net microﬂow at another site (wrist).
While measuring skin microvascular perfusion, LDF probes keep the
skin temperature constant, ruling out the possibility of skin tempera-
ture variation to act as a misleading factor. This technique conﬁrmed
the occurrence of increased blood ﬂow in predominantly non-
nutritive [36] microvessels following cognitive–sensorial stimulus.
In addition, skin insulin iontophoresis performed on both groups at
the end of the protocol conﬁrmed that, irrespective of the group,
healthy volunteers had similar microvascular responsiveness to exog-
enous insulin. Even considering the differences between endogenous
and exogenous stimuli on their actions on vascular tissue, the fact
that both groups had the same microvascular reactivity during exog-
enous insulin iontophoresis reassures that all subjects were able to
react to at least one of the hormones tested.
The absence of signiﬁcant differences on vasomotion between CPD
and control groups strongly suggests that observed increments in FCD
and other microcirculatory variables could be due to arteriolar dilata-
tion. On the other hand, the fact that vasomotion and insulin secre-
tion were not altered during CPD is well in line with ﬁndings of
Renaudin and co-workers [41] that point to an increase in vasomo-
tion related only to concomitantly infused insulin and glucose.
Data on type 2 diabetes mellitus (T2DM) and obese subjects sug-
gest that CPD is impaired [4] and could inﬂuence glucose homeosta-
sis. Although the upcoming study in our research line is to assess
possible microvascular responsiveness in states of T2DM, obesity
and metabolic syndrome during CPD, ﬁrst we needed to assess it in
healthy individuals in order to conﬁrm microcirculatory involvement
in this phase. A phenomenon should be ﬁrst ascertained before one
can begin to understand its mechanistic features. Therefore, this
study was performed as a pilot needed to provide information for fur-
ther pathophysiological investigation. Due to the nature of our out-
come – microvascular function – we have faced a study design
limitation: any attempt of blockage of mechanisms involved in hor-
monal secretion or cholinergic activity during the cephalic phase in
humans (i.e. by somatostatin or its analogs or atropine) would pose
a bias on circulation functioning as well [42].
Physiologically, our results bring up an important novel ﬁnding.
The activation of the microcirculation is perhaps involved in the
CPD as an anticipatory mechanism to the physiological burden associ-
ated with eating, as elegantly reviewed by Woods [43]. Up to this
point, the role of endogenous insulin and its cause–effect relationship
to microcirculatory activation on pre-ingestive phase of digestion
should be kept as a hypothesis, since the action of exogenous insulin
on microcirculation at fasting state [18,20] has already been de-
scribed. We must highlight that another possible explanation for the
observed improvement on microvascular reactivity could be the ef-
fect of parasympathetic stimulus generated by sensorial stimulation
1087C. Buss et al. / Physiology & Behavior 105 (2012) 1082–1087acting on the microcirculation while it does so on exocrine secretions
of the gastro-intestinal tract [7]. However, on the basis of our ﬁndings,
we might suggest that the effect of endocrine secretions secondary to
the same vagal stimulation [7], clinically expressed as PP secretion,
was positively correlated to an increase on basal capillary density. Fu-
ture protocols should be performed to deﬁne the exact clinical and
physiological impact of microcirculatory changes during CPD on
states of disease and its effects on nutrient metabolism and glucose
homeostasis.
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